1268051-62-2

Basic information

• Product Name: N-(3-{1-[5-chloro-1-(2-methoxyethyl)-7-methyl-1H-indole-3-carbonyl]piperidin-4-yl}-4-fluorobenzyl)-2,2,2-trifluoroacetamide
• Synonyms: N-(3-{1-[5-chloro-1-(2-methoxyethyl)-7-methyl-1H-indole-3-carbonyl]piperidin-4-yl}-4-fluorobenzyl)-2,2,2-trifluoroacetamide
• CAS NO: 1268051-62-2
• Molecular Weight: 553.984
• Mol File: 1268051-62-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3-{1-[5-chloro-1-(2-methoxyethyl)-7-methyl-1H-indole-3-carbonyl]piperidin-4-yl}-4-fluorobenzyl)-2,2,2-trifluoroacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-{1-[5-chloro-1-(2-methoxyethyl)-7-methyl-1H-indole-3-carbonyl]piperidin-4-yl}-4-fluorobenzyl)-2,2,2-trifluoroacetamide(1268051-62-2)
• EPA Substance Registry System: N-(3-{1-[5-chloro-1-(2-methoxyethyl)-7-methyl-1H-indole-3-carbonyl]piperidin-4-yl}-4-fluorobenzyl)-2,2,2-trifluoroacetamide(1268051-62-2)

Safety Data

• Hazardous Substances Data: 1268051-62-2(Hazardous Substances Data)

Upstream product

• 1268051-59-7 1-[5-chloro-1-(2-methoxyethyl)-7-methyl-1H-indol-3-yl]-2,2,2-trifluoroethanone 
• 1268051-58-6 5-chloro-1-(2-methoxyethyl)-7-methyl-1H-indole 
• 15936-77-3 5-chloro-7-methyl-1H-indole 
• 1208977-19-8 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide hydrochloride 
• 1067427-53-5 2,2,2-trifluoro-N-(4-fluoro-3-piperidin-4-yl-benzyl)acetamide hydrochloride 
• 1268051-60-0 5-chloro-1-(2-methoxyethyl)-7-methyl-1H-indole-3-carboxylic acid 
• 202865-68-7 3-bromo-4-fluoro-benzylamine hydrochloride 
• 14389-06-1 5-chloro-7-methyl-1H-indole-2,3-dione 
• 1692-15-5 4-pyridylboronic acid 

Downstream Products

• 1268051-05-3 [4-(5-aminomethyl-2-fluorophenyl)-piperidin-1-yl]-[5-chloro-1-(2-methoxy-ethyl)-7-methyl-1H-indol-3-yl]methanone hydrochloride 

Relevant articles and documents

DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES

The present invention extends to the compound of formula I: or a prodrug, pharmaceutically acceptable salt, or solvate of said compound. Furthermore, the present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective